Clinical Trials Logo

Filter by:
NCT ID: NCT06407791 Not yet recruiting - Lymphedema Clinical Trials

Clinical Evaluation of a Device for Treatment of Lymphedema of the Upper Extremity

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

Lymphedema is a painful and disfiguring condition related to the buildup of protein-rich fluid in the body's tissues. The goal of this research study is to determine the safety and efficacy of a novel, proprietary device in the treatment of upper extremity lymphedema. This device has been previously studied on healthy people that do not have a diagnosis of lymphedema. It was found that using the device on them does not cause significant changes to their vital signs or level of pain. Side effects are reported sometimes; however, these are to be expected and are also frequently reported when people receive the standard of care for their lymphedema. Patients who have diagnosed lymphedema will be approached to participate in this study as part of their care. Participants will wear this device for approximately 40 minutes and then have certain measurements taken before and after doing so. These measurements include the size of their arm, how much pain/discomfort they are currently in, and if they experienced any side effects. After getting treatment with the device, they will receive the standard of care treatment for their lymphedema from their provider. After the standard of care has concluded, the previously mentioned measurements will be repeated. This data will be put together and analyzed to look for differences in arm size before and after treatment with the device as well as to look for the prevalence of side effects.

NCT ID: NCT06407648 Recruiting - Clinical trials for Obsessive-Compulsive Disorder

Using Personalized Assessments in the Treatment of Childhood OCD

Start date: April 3, 2024
Phase: N/A
Study type: Interventional

The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are feasible and acceptable for youth and parents. The investigators will also examine whether personalized cognitive-behavioral therapy (CBT) that is informed by personalized OCD assessments yields better clinical outcomes when compared to standard CBT for youth with OCD

NCT ID: NCT06407635 Recruiting - Clinical trials for Post Traumatic Stress Disorder

A Study of Psilocybin for PTSD

Start date: June 7, 2024
Phase: Phase 1
Study type: Interventional

The proposed open-label, controlled study at the Johns Hopkins Center for Psychedelic and Consciousness Research (CPCR) will test the following primary hypotheses in adult patients with chronic PTSD who are currently taking a serotonin reuptake inhibitor: psilocybin therapy will be feasible and safe for participants, significantly remediate PTSD symptoms, and enhance wellbeing and quality of life. In addition, the study will examine whether elements of evidence-based trauma-focused psychotherapy enhance treatment response when paired with psilocybin.

NCT ID: NCT06407388 Recruiting - Diabetes Clinical Trials

Ultrasound Findings in Diabetic Pregnancies

Start date: June 1, 2023
Phase:
Study type: Observational

The goal of our study is to identify ultrasonographic markers that can predict adverse neonatal outcomes. Specifically, we hypothesize that an increase in fetal liver volumes will increase transcutaneous bilirubin (TcB) in the newborn and thus jaundice requiring phototherapy. This information can be used in patient counseling and to guide future screening protocols for ultrasound in individuals with diabetes.

NCT ID: NCT06407284 Not yet recruiting - Child Obesity Clinical Trials

Brighter Bites/Legacy Produce Rx Program

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effectiveness of the produce prescription program at improving weight status and obesity-related health outcomes of participants, to examine the impacts of the program on household food insecurity and nutrition security, to examine the impacts of the program on participating adolescents' dietary behavioral outcomes, their home nutrition environment and feeding practices and to examine the impacts of the program in reducing healthcare use and associated costs

NCT ID: NCT06407232 Not yet recruiting - Clinical trials for Cytomegalovirus Infections

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Start date: June 2024
Phase: Phase 3
Study type: Interventional

This study is designed to assess how effective letermovir is in preventing recurrence of cytomegalovirus (CMV) infection in adult kidney or kidney/pancreas transplant recipients who are UW Health patients. Participants will be in the study for about 6 months.

NCT ID: NCT06407115 Enrolling by invitation - Chronic Pain Clinical Trials

Adapting and Implementing a Nurse Care Management Model to Care for Rural Patients With Chronic Pain

AIM-CP
Start date: May 20, 2024
Phase: N/A
Study type: Interventional

Chronic pain affects over 20% U.S. adults and has debilitating effects on quality of life and physical and mental health. Individuals living in rural communities experience higher rates of chronic pain as well as poorer health outcomes due to pain. The 46 million Americans who live in rural areas frequently lack access to evidence-based, non-pharmacologic treatments for chronic pain. As such, a critical need exists to implement effective, comprehensive programs for pain management that include treatment options other than medications. Nurse care management (NCM) has been successfully used to enhance care for individuals with other long-term health issues. The study teams proposes to adapt, pilot, and implement a NCM model that includes care coordination, cognitive behavioral therapy (CBT), and referrals to a remotely delivered exercise program for rural patients with chronic pain.

NCT ID: NCT06407050 Recruiting - Metabolism Clinical Trials

Duration of Physical Inactivity and Postprandial Lipid Metabolism

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the effect of different periods of physical inactivity on postprandial lipid metabolism in the morning after exercise by measuring plasma triglyceride levels and fat oxidation (burning). The study is a crossover intervention with all healthy participants performing three trials varying in length of physical inactive (4 hours, 8 hours, and 12 hours). All trials include a physical activity control phase (>8,500 steps/24hr), a physical inactive phase, a moderate intensity cycling session, and a high-fat tolerance test.

NCT ID: NCT06407024 Not yet recruiting - Adrenalectomy Clinical Trials

Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This study is being done to compare Laparoscopic vs Robotic lateral transabdominal adrenalectomy, these procedures are both standard of care. The study team would like to compare both patient outcomes and surgeon efficiency and perspectives among both procedures. The information from this study will help improve patient care, patient outcomes and maximize the appropriate utilization of resources in adrenal surgery.

NCT ID: NCT06406855 Recruiting - Clinical trials for Spinal Cord Injuries

Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cord Injury (SCI)

Start date: May 7, 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to test the effectiveness of a new therapy, called Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS), for improving walking in people with an incomplete spinal cord injury (SCI).